- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 8 residues within 4Å:- Chain A: A.163, L.164, N.165, R.201, N.246, S.247, T.248
- Ligands: NAG-NAG-MAN.1
1 PLIP interactions:1 interactions with chain B- Water bridges: B:D.188
NAG-NAG.13: 8 residues within 4Å:- Chain B: A.163, L.164, N.165, R.201, N.246, S.247, T.248
- Ligands: NAG-NAG-MAN.12
1 PLIP interactions:1 interactions with chain C- Water bridges: C:D.188
NAG-NAG.24: 8 residues within 4Å:- Chain C: A.163, L.164, N.165, R.201, N.246, S.247, T.248
- Ligands: NAG-NAG-MAN.23
1 PLIP interactions:1 interactions with chain A- Water bridges: A:D.188
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.3: 3 residues within 4Å:- Chain A: N.38, T.318, L.381
Ligand excluded by PLIPNAG.4: 3 residues within 4Å:- Chain A: E.62, N.63, Y.94
Ligand excluded by PLIPNAG.5: 2 residues within 4Å:- Chain A: N.133
- Ligands: EPE.9
Ligand excluded by PLIPNAG.6: 5 residues within 4Å:- Chain A: S.45, N.285, V.297, N.298, E.398
Ligand excluded by PLIPNAG.7: 2 residues within 4Å:- Chain A: N.126, T.128
Ligand excluded by PLIPNAG.8: 3 residues within 4Å:- Chain A: G.479, R.482, N.483
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain B: N.38, T.318, L.381
Ligand excluded by PLIPNAG.15: 3 residues within 4Å:- Chain B: E.62, N.63, Y.94
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain B: N.133
- Ligands: EPE.20
Ligand excluded by PLIPNAG.17: 5 residues within 4Å:- Chain B: S.45, N.285, V.297, N.298, E.398
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain B: N.126, T.128
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain B: G.479, R.482, N.483
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain C: N.38, T.318, L.381
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain C: E.62, N.63, Y.94
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain C: N.133
- Ligands: EPE.31
Ligand excluded by PLIPNAG.28: 5 residues within 4Å:- Chain C: S.45, N.285, V.297, N.298, E.398
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain C: N.126, T.128
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain C: G.479, R.482, N.483
Ligand excluded by PLIP- 6 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
EPE.9: 10 residues within 4Å:- Chain A: D.77, Q.80, R.141, S.146, F.147, F.148, S.149, L.151, R.255
- Ligands: NAG.5
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:Q.80, A:Q.80, A:L.151, A:R.255
- Salt bridges: A:R.141
EPE.10: 9 residues within 4Å:- Chain A: S.95, Y.98, P.99, Y.100, Y.105, V.223, R.224, E.401
- Chain C: R.208
9 PLIP interactions:8 interactions with chain A, 1 interactions with chain C- Hydrogen bonds: A:S.95, A:Y.100, A:Y.100, A:E.401, C:R.208
- Water bridges: A:S.95, A:R.224
- Salt bridges: A:R.224
- pi-Cation interactions: A:Y.105
EPE.20: 10 residues within 4Å:- Chain B: D.77, Q.80, R.141, S.146, F.147, F.148, S.149, L.151, R.255
- Ligands: NAG.16
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:Q.80, B:Q.80, B:L.151, B:R.255
- Salt bridges: B:R.141
EPE.21: 9 residues within 4Å:- Chain A: R.208
- Chain B: S.95, Y.98, P.99, Y.100, Y.105, V.223, R.224, E.401
9 PLIP interactions:8 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:S.95, B:Y.100, B:Y.100, B:E.401, A:R.208
- Water bridges: B:S.95, B:R.224
- Salt bridges: B:R.224
- pi-Cation interactions: B:Y.105
EPE.31: 10 residues within 4Å:- Chain C: D.77, Q.80, R.141, S.146, F.147, F.148, S.149, L.151, R.255
- Ligands: NAG.27
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:Q.80, C:Q.80, C:L.151, C:R.255
- Salt bridges: C:R.141
EPE.32: 9 residues within 4Å:- Chain B: R.208
- Chain C: S.95, Y.98, P.99, Y.100, Y.105, V.223, R.224, E.401
9 PLIP interactions:1 interactions with chain B, 8 interactions with chain C- Hydrogen bonds: B:R.208, C:S.95, C:Y.100, C:Y.100, C:E.401
- Water bridges: C:S.95, C:R.224
- Salt bridges: C:R.224
- pi-Cation interactions: C:Y.105
- 3 x TAM: TRIS(HYDROXYETHYL)AMINOMETHANE(Non-covalent)
TAM.11: 1 residues within 4Å:- Chain A: R.383
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:R.383
TAM.22: 1 residues within 4Å:- Chain B: R.383
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.383
TAM.33: 1 residues within 4Å:- Chain C: R.383
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:R.383
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lin, Y.P. et al., Evolution of the Receptor Binding Properties of the Influenza A(H3N2) Hemagglutinin. Proc.Natl.Acad.Sci.USA (2012)
- Release Date
- 2012-11-07
- Peptides
- HEMAGGLUTININ: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x EPE: 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
- 3 x TAM: TRIS(HYDROXYETHYL)AMINOMETHANE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Lin, Y.P. et al., Evolution of the Receptor Binding Properties of the Influenza A(H3N2) Hemagglutinin. Proc.Natl.Acad.Sci.USA (2012)
- Release Date
- 2012-11-07
- Peptides
- HEMAGGLUTININ: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A